Related references
Note: Only part of the references are listed.Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2
Yuchun Niu et al.
MOLECULAR CANCER (2017)
Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway
Hui Shi et al.
TUMOR BIOLOGY (2017)
Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma
Kaiming Ren et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
David M. Walter et al.
CANCER RESEARCH (2017)
Transcriptome analysis of EGFR tyrosine kinase inhibitors resistance associated long noncoding RNA in non-small cell lung cancer
Pei Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells
Shun Fang et al.
LABORATORY INVESTIGATION (2016)
Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray
Ying Wu et al.
ONCOLOGY REPORTS (2016)
NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells
Pan Jiang et al.
ONCOTARGET (2016)
Long non-coding RNA BC087858 induces non-T790M mutation acquired resistance to EGFR-TKIs by activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell lung cancer
Hui Pan et al.
ONCOTARGET (2016)
Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
Jing Chen et al.
ONCOTARGET (2016)
Elevated HOTAIR expression associated with cisplatin resistance in non-small cell lung cancer patients
Ming-Yue Liu et al.
JOURNAL OF THORACIC DISEASE (2016)
Long Non-Coding RNAs in Cancer and Development: Where Do We Go from Here?
Monika Haemmerle et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway
Yang Xia et al.
MOLECULAR MEDICINE REPORTS (2015)
Long Noncoding RNA MALAT-1 Can Predict Metastasis and a Poor Prognosis: a Meta-Analysis
Lucheng Zhu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Frequent loss of the expression of multiple subunits of the SWI/SNF complex in large cell carcinoma and pleomorphic carcinoma of the lung
Taichiro Yoshimoto et al.
PATHOLOGY INTERNATIONAL (2015)
Epigenetics of lung cancer
Scott M. Langevin et al.
TRANSLATIONAL RESEARCH (2015)
Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer
Ningning Cheng et al.
ONCOTARGET (2015)
Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer
Namrata Bora-Singhal et al.
NEOPLASIA (2015)
Targeting the histone orthography of cancer: drugs for writers, erasers and readers
Laia Simo-Riudalbas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancer
Ningning Cheng et al.
ONCOLOGY REPORTS (2015)
The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
Jing Liu et al.
PLOS ONE (2015)
The Clonal Evolution and Therapeutic Approaches of Lung Cancer
Haixiang Yu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival
Zhibo Hou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Identification of novel non-coding RNA-based negative feedback regulating the expression of the oncogenic transcription factor GLI1
Victoria E. Villegas et al.
MOLECULAR ONCOLOGY (2014)
Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer
Marjan E. Askarian-Amiri et al.
PLOS ONE (2014)
Overexpression of MEOX2 and TWIST1 Is Associated with H3K27me3 Levels and Determines Lung Cancer Chemoresistance and Prognosis
Federico Avila-Moreno et al.
PLOS ONE (2014)
HP1a: a structural chromosomal protein regulating transcription
Joel C. Eissenberg et al.
TRENDS IN GENETICS (2014)
ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis
Yi Zhang et al.
TUMOR BIOLOGY (2014)
Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer
Jie Luo et al.
TUMOR BIOLOGY (2014)
Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
Kohji Noguchi et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2014)
Long noncoding RNAs and the genetics of cancer
S. W. Cheetham et al.
BRITISH JOURNAL OF CANCER (2013)
Targeting long non-coding RNAs in cancers: Progress and prospects
Chi Han Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer
Xiaohui Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistant Disease
Kadoaki Ohashi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The significance of epigenetic alterations in lung carcinogenesis
Ewa Brzezianska et al.
MOLECULAR BIOLOGY REPORTS (2013)
The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
Yong Yang et al.
PLOS ONE (2013)
The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 Expression
Zhili Liu et al.
PLOS ONE (2013)
Mechanisms of chemoresistance in cancer stem cells
Lissa Nurrul Abdullah et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2013)
Epigenetics of colorectal cancer
F. Migheli et al.
CLINICAL GENETICS (2012)
Regulatory long non-coding RNA and its functions
Yong Huang et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2012)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients
Joon Seon Song et al.
PATHOLOGY INTERNATIONAL (2012)
EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer
Wei Cao et al.
PLOS ONE (2012)
Utilisation of Nanoparticle Technology in Cancer Chemoresistance
Duncan Ayers et al.
JOURNAL OF DRUG DELIVERY (2012)
Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification
Minjia Tan et al.
CELL (2011)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Alex Chang
LUNG CANCER (2011)
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
Kevin C. Wang et al.
NATURE (2011)
Long noncoding RNAs and human disease
Orly Wapinski et al.
TRENDS IN CELL BIOLOGY (2011)
Epigenetics and lifestyle
Jorge Alejandro Alegra-Torres et al.
EPIGENOMICS (2011)
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Miao-Chih Tsai et al.
SCIENCE (2010)
Deconstructing the Dogma A New View of the Evolution and Genetic Programming of Complex Organisms
John S. Mattick
NATURAL GENETIC ENGINEERING AND NATURAL GENOME EDITING (2009)
Epigenetics and environmental chemicals
Andrea Baccarelli et al.
CURRENT OPINION IN PEDIATRICS (2009)
Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus
Ching Tzao et al.
MODERN PATHOLOGY (2009)
Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression
Ahmad M. Khalil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non-Small Cell Lung Cancer (Publication with Expression of Concern. See vol. 26, pg. 2768, 2020)
Arnaud Van Den Broeck et al.
CLINICAL CANCER RESEARCH (2008)
Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer
Pedro P. Medina et al.
EPIGENETICS (2008)
Chemoresistance in gliomas
Chen Lu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Differentiating Protein-Coding and Noncoding RNA: Challenges and Ambiguities
Marcel E. Dinger et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Global histone modifications predict prognosis of resected non-small-cell lung cancer
Fabrice Barlesi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR
Wing Pui Tsang et al.
RNA (2007)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
Structures of protein domains that create or recognize histone modifications
MJ Bottomley
EMBO REPORTS (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The evolution of controlled multitasked gene networks: The role of introns and other noncoding RNAs in the development of complex organisms
JS Mattick et al.
MOLECULAR BIOLOGY AND EVOLUTION (2001)
Cisplatin resistance and oncogene - a review
W Dempke et al.
ANTI-CANCER DRUGS (2000)
The language of covalent histone modifications
BD Strahl et al.
NATURE (2000)